Stacy Loeb, MD MSc PhD (hc)
Stacy Loeb, MD MSc PhD (hc)
New York University and Manhattan VA
Verified email at - Homepage
Cited by
Cited by
Systematic review of complications of prostate biopsy
S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton, R Nam, ...
European urology 64 (6), 876-892, 2013
Complications after prostate biopsy: data from SEER-Medicare
S Loeb, HB Carter, SI Berndt, W Ricker, EM Schaeffer
The Journal of urology 186 (5), 1830-1834, 2011
Overdiagnosis and overtreatment of prostate cancer
S Loeb, MA Bjurlin, J Nicholson, TL Tammela, DF Penson, HB Carter, ...
European urology 65 (6), 1046-1055, 2014
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
Infectious complications and hospital admissions after prostate biopsy in a European randomized trial
S Loeb, S van den Heuvel, X Zhu, CH Bangma, FH Schröder, MJ Roobol
European urology 61 (6), 1110-1114, 2012
Re: Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program
AE Ross, S Loeb, P Landis
J Clin Oncol 28, 2810-6, 2010
Biomarkers for prostate cancer
DV Makarov, S Loeb, RH Getzenberg, AW Partin
Annual review of medicine 60, 139-151, 2009
The prostate health index selectively identifies clinically significant prostate cancer
S Loeb, MG Sanda, DL Broyles, SS Shin, CH Bangma, JT Wei, AW Partin, ...
The Journal of urology 193 (4), 1163-1169, 2015
Characteristics of prostate cancer detected by digital rectal examination only
OT Okotie, KA Roehl, M Han, S Loeb, SN Gashti, WJ Catalona
Urology 70 (6), 1117-1120, 2007
Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old
S Loeb, KA Roehl, JAV Antenor, WJ Catalona, BK Suarez, RB Nadler
Urology 67 (2), 316-320, 2006
Active surveillance for prostate cancer: current evidence and contemporary state of practice
JJ Tosoian, HB Carter, A Lepor, S Loeb
Nature Reviews Urology 13 (4), 205-215, 2016
Complications after systematic, random, and image-guided prostate biopsy
M Borghesi, H Ahmed, R Nam, E Schaeffer, R Schiavina, S Taneja, ...
European urology 71 (3), 353-365, 2017
Genomic predictors of outcome in prostate cancer
PJ Boström, AS Bjartell, JWF Catto, SE Eggener, H Lilja, S Loeb, ...
European urology 68 (6), 1033-1044, 2015
The Prostate Health Index: a new test for the detection of prostate cancer
S Loeb, WJ Catalona
Therapeutic advances in urology 6 (2), 74-77, 2014
Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer
S Loeb, ND Smith, KA Roehl, WJ Catalona
Urology 69 (6), 1170-1175, 2007
Prostate-specific antigen in clinical practice
S Loeb, WJ Catalona
Cancer letters 249 (1), 30-39, 2007
Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators
MJ Roobol, HA van Vugt, S Loeb, X Zhu, M Bul, CH Bangma, ...
European urology 61 (3), 577-583, 2012
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program
JJ Tosoian, S Loeb, A Kettermann, P Landis, DJ Elliot, JI Epstein, ...
The Journal of urology 183 (2), 534-538, 2010
Use of social media in urology: data from the A merican U rological A ssociation (AUA)
S Loeb, CE Bayne, C Frey, BJ Davies, TD Averch, HH Woo, B Stork, ...
BJU international 113 (6), 993-998, 2014
What are the outcomes of radical prostatectomy for high-risk prostate cancer?
S Loeb, EM Schaeffer, BJ Trock, JI Epstein, EB Humphreys, PC Walsh
Urology 76 (3), 710-714, 2010
The system can't perform the operation now. Try again later.
Articles 1–20